Ascorbic Acid and Combination Chemotherapy in Treating Patients With Locally Advanced or Recurrent Pancreatic Cancer That Cannot Be Removed by Surgery
Early Phase 1
Completed
- Conditions
- Unresectable Pancreatic CarcinomaStage III Pancreatic CancerPancreatic AdenocarcinomaRecurrent Pancreatic CarcinomaStage IV Pancreatic Cancer
- Interventions
- Drug: OxaliplatinDrug: Irinotecan HydrochlorideDrug: Leucovorin CalciumDrug: FluorouracilDietary Supplement: Ascorbic Acid
- First Posted Date
- 2016-09-12
- Last Posted Date
- 2020-01-18
- Target Recruit Count
- 8
- Registration Number
- NCT02896907
- Locations
- 🇺🇸
Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Metformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine Cancer
Phase 2
Active, not recruiting
- Conditions
- Breast CarcinomaEndometrial Clear Cell AdenocarcinomaUterine Corpus CancerEndometrial Serous AdenocarcinomaUterine Corpus Carcinosarcoma
- Interventions
- First Posted Date
- 2016-08-22
- Last Posted Date
- 2022-12-15
- Target Recruit Count
- 27
- Registration Number
- NCT02874430
- Locations
- 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States
CAREFOR: Precision Medicine Driving Precision Nutrition for the Treatment of NeoAdjuvant Breast Cancer
Not Applicable
Completed
- Conditions
- Breast Carcinoma
- Interventions
- Behavioral: Behavioral Dietary Intervention
- First Posted Date
- 2016-07-11
- Last Posted Date
- 2023-07-17
- Target Recruit Count
- 26
- Registration Number
- NCT02827370
- Locations
- 🇺🇸
Sidney Kimmel Cancer Center at Thomas Jefferson Univeristy, Philadelphia, Pennsylvania, United States
Positron Emission Tomography Imaging Using Copper Cu 64 TP3805 in Patients With Breast Cancer
Not Applicable
Terminated
- Conditions
- Breast Carcinoma
- Interventions
- Device: Positron Emission MammographyDevice: Positron Emission TomographyRadiation: Fludeoxyglucose F-18Drug: Copper Cu 64 TP3805
- First Posted Date
- 2016-06-23
- Last Posted Date
- 2018-01-09
- Target Recruit Count
- 19
- Registration Number
- NCT02810873
Contrast-enhanced Ultrasound Evaluation of Chemoembolization
Phase 3
Completed
- Conditions
- Hepatocellular CarcinomaChemoembolization, Therapeutic
- Interventions
- Drug: Ultrasound contrast agent (Contrast-enhanced ultrasound)Device: Logiq E9 Scanner (Contrast-enhanced ultrasound)
- First Posted Date
- 2016-05-06
- Last Posted Date
- 2023-12-19
- Target Recruit Count
- 131
- Registration Number
- NCT02764801
- Locations
- 🇺🇸
University of California, San Diego, La Jolla, California, United States
🇺🇸Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Desensitizing Distressing Recollections in Cancer Patients
Not Applicable
Completed
- Conditions
- Cancer
- Interventions
- Behavioral: NET Intervention
- First Posted Date
- 2016-05-03
- Last Posted Date
- 2018-06-13
- Target Recruit Count
- 44
- Registration Number
- NCT02760524
- Locations
- 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States
High Volume Washing of the Abdomen in Increasing Survival After Surgery in Patients With Pancreatic Cancer That Can Be Removed by Surgery
Not Applicable
Recruiting
- Conditions
- Ampulla of Vater AdenocarcinomaCholangiocarcinomaDuodenal AdenocarcinomaAcinar Cell CarcinomaPancreatic AdenocarcinomaPancreatic Ductal AdenocarcinomaPancreatic Intraductal Papillary Mucinous NeoplasmPeriampullary Adenocarcinoma
- Interventions
- Procedure: PancreatectomyOther: Lavage
- First Posted Date
- 2016-05-02
- Last Posted Date
- 2024-07-03
- Target Recruit Count
- 845
- Registration Number
- NCT02757859
- Locations
- 🇺🇸
Case Western Reserve University, Cleveland, Ohio, United States
🇺🇸Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Telehealth in Improving Quality of Life in Patients During Post Radiation Therapy Visits
Not Applicable
Completed
- Conditions
- Malignant Neoplasm
- Interventions
- Other: TelemedicineOther: Questionnaire Administration
- First Posted Date
- 2016-04-26
- Last Posted Date
- 2024-01-24
- Target Recruit Count
- 37
- Registration Number
- NCT02751580
- Locations
- 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Contrast-Enhanced Ultrasound in Predicting Treatment Response in Patients With Kidney Cancer Undergoing Cryosurgery
Early Phase 1
Withdrawn
- Conditions
- Renal Cell Carcinoma
- Interventions
- Drug: Perflutren Protein-Type A MicrospheresProcedure: Dynamic Contrast-Enhanced Ultrasound Imaging
- Locations
- 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Contrast Ultrasound Detection of Sentinel Lymph Nodes
Phase 1
Completed
- Conditions
- Breast Cancer
- Interventions
- Drug: Sonazoid; Perflubutane for Injection
- First Posted Date
- 2016-01-12
- Last Posted Date
- 2023-01-23
- Target Recruit Count
- 98
- Registration Number
- NCT02652923
- Locations
- 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States
© Copyright 2025. All Rights Reserved by MedPath